sequenom

  NEW YORK, Feb 15 – Due to strong sales of its MassArray SNP analysis technology, Sequenom reported increased revenues for the fourth quarter and year-end Thursday, while expenses also doubled from the fourth quarter of 1999. 
    
  Sequenom’s fourth quarter revenues totaled $3.7 million, compared to $98,000 for the year-ago quarter, and year-end revenues totaled $10 million, compared to $179,000 for 1999. 
    

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.